JHX

Business Context and Reporting Period

Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2018 (Filed September 20, 2018)
Context: This filing serves as a cover document for materials presented during the "2018 USA Investor Tour." It does not contain a standalone financial report but rather references presentations regarding company updates, operations, sales, and safety initiatives.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as topics covered in the attached investor tour presentations (Exhibits 99.1 through 99.11) but are not detailed within the body of this Form 6-K.

Material Changes

No material financial changes or comparative period data are disclosed in this specific document. The filing indicates that updates on operations and strategy were delivered during the investor tour events.

Guidance, Outlook, and Risks

Forward-Looking Statements: The document contains an extensive disclaimer regarding forward-looking statements. These include projections on future performance, capital expenditure projects, credit facility renewals, dividend payments, and share buy-backs.
Key Risks Identified:

• Asbestos Liability: Risks related to prior asbestos manufacturing, including contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls, and currency exchange impacts on liabilities.
• Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
• Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
• Operational: Integration of Fermacell, raw material costs, and competition.
• Financial: Currency exchange risks and the ability to renew credit facilities on favorable terms.

Management Commentary: The filing lists presentations by senior executives (Louis Gries, Ryan Kilcullen, Matt Marsh, Dave Merkley, Sean Gadd, Zean Nielsen, Jack Truong) covering company updates, "Zero Harm" safety initiatives, operations, and regional sales strategies.

Investor Verification Checklist

• Review the attached Exhibits (99.1–99.11) for specific financial data and strategic updates presented during the 2018 USA Investor Tour.
• Verify the current status and funding adequacy of the Asbestos Injuries Compensation Fund (AICF).
• Monitor the integration progress of the Fermacell acquisition.
• Assess the impact of currency exchange rates on reported liabilities and earnings.
• Check for updates on credit facility terms and covenants.